Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4476
Avalo Therapeutics
AVTX
$1.03B
| $119K | ﹤0.01% |
+9,346
| New | +$80.4K |
|
4477
Waldencast
WALD
$219M
| $118K | ﹤0.01% |
59,750
-14,282
| -19% | -$28.6K |
|
4478
ATS Corp
ATS
$2.6B
| $118K | ﹤0.01% |
4,508
-17,120
| -79% | -$493K |
|
4479
Virco
VIRC
$94.4M
| $118K | ﹤0.01% |
15,170
-3,191
| -17% | -$26K |
|
4480
Bally's
BALY
$700M
| $117K | ﹤0.01% |
10,537
-2,790
| -21% | -$28.1K |
|
4481
Consumer Portfolio Services
CPSS
$208M
| $115K | ﹤0.01% |
15,189
-1,041
| -6% | -$8.88K |
|
4482
WisdomTree Artificial Intelligence and Innovation Fund
WTAI
$580M
| $114K | ﹤0.01% |
4,000
| – | – |
|
4483
Fiverr
FVRR
$330M
| $114K | ﹤0.01% |
4,679
-9,383
| -67% | -$230K |
|
|
OBE
4484
Obsidian Energy
OBE
$678M
| $114K | ﹤0.01% |
17,426
+300
| +2% | +$1.78K |
|
4485
CSP Inc
CSPI
$79.2M
| $114K | ﹤0.01% |
9,867
-2,995
| -23% | -$35.1K |
|
|
TSE
4486
DELISTED
Trinseo
TSE
| $113K | ﹤0.01% |
47,982
-10,916
| -19% | -$28.4K |
|
4487
MediciNova
MNOV
$66M
| $113K | ﹤0.01% |
88,615
-19,385
| -18% | -$25.1K |
|
4488
Innovator US Equity Buffer ETF December
BDEC
$217M
| $112K | ﹤0.01% |
2,337
+1,576
| +207% | +$73.1K |
|
4489
AllianzIM U.S. Equity Buffer10 Sep ETF
SEPT
$33M
| $112K | ﹤0.01% |
3,247
-1,449
| -31% | -$48.2K |
|
|
INFA
4490
DELISTED
Informatica
INFA
| $112K | ﹤0.01% |
4,505
-246,620
| -98% | -$6.08M |
|
4491
FitLife Brands
FTLF
$92.9M
| $112K | ﹤0.01% |
5,626
-1,189
| -17% | -$19.1K |
|
4492
Nuvectis Pharma
NVCT
$718M
| $111K | ﹤0.01% |
18,425
-4,749
| -20% | -$32.6K |
|
|
MPX
4493
DELISTED
Marine Products Corp
MPX
| $111K | ﹤0.01% |
12,503
-3,070
| -20% | -$27.3K |
|
4494
CALL
Charter Communications
CHTR
$16.9B
| $110K | ﹤0.01% |
400
| – | – |
|
4495
iShares US Healthcare Providers ETF
IHF
$1.21B
| $110K | ﹤0.01% |
2,225
| – | – |
|
4496
Instil Bio
TIL
$48.4M
| $110K | ﹤0.01% |
6,150
-4,250
| -41% | -$108K |
|
4497
Geospace Technologies
GEOS
$93.1M
| $109K | ﹤0.01% |
5,761
+5,760
| +576,000% | +$93.3K |
|
4498
Vanguard Morningstar Growth ETF
VUG
$218B
| $109K | ﹤0.01% |
1,362
| – | – |
|
|
TBN
4499
Tamboran Resources
TBN
$1.14B
| $108K | ﹤0.01% |
3,946
+3,170
| +409% | +$65.5K |
|
4500
Innovator US Equity Ultra Buffer ETF June
UJUN
$185M
| $107K | ﹤0.01% |
2,913
+2
| +0.1% | +$72 |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.